Survival Time Outcomes in Randomized, Controlled Trials and Meta-Analyses: The Parallel Universes of Efficacy and Cost-Effectiveness
- 31 August 2011
- journal article
- research article
- Published by Elsevier BV in Value in Health
- Vol. 14 (5), 640-646
- https://doi.org/10.1016/j.jval.2011.01.008
Abstract
No abstract availableKeywords
Funding Information
- Medical Research Council
- University of Bristol
This publication has 6 references indexed in Scilit:
- Survival models in health economic evaluations: balancing fit and parsimony to improve prediction.The International Journal of Biostatistics, 2010
- Structural and Parameter Uncertainty in Bayesian Cost-Effectiveness ModelsJournal of the Royal Statistical Society Series C: Applied Statistics, 2009
- Accounting for Uncertainty in Health Economic Decision Models by Using Model AveragingJournal of the Royal Statistical Society Series A: Statistics in Society, 2009
- The generalized F distribution: An umbrella for parametric survival analysisStatistics in Medicine, 2008
- Simultaneous comparison of multiple treatments: combining direct and indirect evidenceBMJ, 2005
- Flexible parametric proportional‐hazards and proportional‐odds models for censored survival data, with application to prognostic modelling and estimation of treatment effectsStatistics in Medicine, 2002